
4.87 Delayed Data As of Jun 09 | ![]() Today’s Change | 4.02 Today|||52-Week Range 37.13 | -51.78% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $516.5M |
Fate Therapeutics, Inc. 12278 Scripps Summit Drive San Diego California 92131 |
J. Scott Wolchko | President, Chief Executive Officer & Director |
Edward J. Dulac | Chief Financial Officer & Accounting Officer |
Bahram Valamehr | Chief Research & Development Officer |
Wen Bo Wang | Senior Vice President-Technical Operations |
Yu Waye Chu | Chief Medical Officer |